N-Heterocyclic Carbenes as Ligands to 198Au(I) Radiolabeled Compounds: a New Platform for Radiopharmaceutical Design
Authors:
- Sarah SpreckelmeyerSSSarah Spreckelmeyer
- Sophie ThomasSTSophie Thomas
- Franziska SchudererFSFranziska Schuderer
- Catarina PintoCPCatarina Pinto
- Ana Luiza de Andrade QuerinoAQAna Luiza de Andrade Querino
- Mihyun ParkMPMihyun Park
- Christopher GeppertCGChristopher Geppert
- Christian GorgesCGChristian Gorges
- Filipa MendesFilipa Mendes
- Angela CasiniACAngela Casini
Preprint
- 17 April 2025
- preprint
- Published by American Chemical Society (ACS) in ChemRxiv
Abstract
The application of Au(I) ions in pharmaceuticals, including in nuclear medicine, is limited by their instability towards reduction in vivo. The gold radionuclide 198Au with a half-life of 2.7 days emits gamma radiation ideal for diagnostic purposes and also generates β- particles suitable for effective cancer radiotherapy, making it a perfect nuclide for ‘theranostics’. Here, we explore N-heterocyclic carbene (NHC) organometallic chemistry to stabilize 198Au(I) in radiopharmaceuticals. Thus, different Au(I) NHC compounds featuring different scaffolds have been selected for 198Au radiolabeling. Two new benzimidazol-2-ylidene Au(I) complexes bearing peptide ligands enabling blood brain barrier translocation in vitro have also been synthesized and their radiolabeling attempted. The obtained proof-of-concept results showed that NHCs are suitable ligands to achieve isotope exchange in Au(I) complexes, with imidazole derivatives being particularly stable, also in the presence of AuCl(THT) and human serum albumin. Overall, our work reveals the still untapped potential of organometallic chemistry in radiopharmaceutical design.Keywords
All Related Versions
This publication has 47 references indexed in Scilit:
- Gold Complexes in Anticancer Therapy: From New Design Principles to Particle‐Based Delivery SystemsAngewandte Chemie International Edition, 2023
- Synthesis and antiproliferative study of phosphorescent multimetallic Re(I)/Au(I) complexes containing fused imidazo[4,5‐f]‐1,10‐phenanthroline coreApplied Organometallic Chemistry, 2022
- Organometallic Chemistry of Gold-Based Drugs2022
- Gold(I) and Gold(III) N‐Heterocyclic Carbene Complexes as Antibacterial Agents and Inhibitors of Bacterial Thioredoxin ReductaseChemMedChem, 2021
- Radiolabeling of Gold Nanocages for Potential Applications in Tracking, Diagnosis, and Image‐Guided TherapyAdvanced Healthcare Materials, 2021
- 124I Radiolabeling of a AuIII‐NHC Complex for In Vivo Biodistribution StudiesAngewandte Chemie International Edition, 2020
- Water‐Soluble N‐Heterocyclic Carbene‐Protected Gold Nanoparticles: Size‐Controlled Synthesis, Stability, and Optical PropertiesAngewandte Chemie International Edition, 2017
- Gold Nanoparticles Doped with 199Au Atoms and Their Use for Targeted Cancer Imaging by SPECTAdvanced Healthcare Materials, 2016
- Biodistribution of a potential chemotherapeutic, dinuclearbisphosphinogold(I) dithiocarbamate, as determined by its 198Au radiolabelled analogueJournal of Radioanalytical and Nuclear Chemistry, 2014
- New Gold(I) Organometallic Compounds with Biological Activity in Cancer CellsEuropean Journal of Inorganic Chemistry, 2014